Items where authors include "Di Battista, M."

Article

Di Battista, M., Colak, S., Howard, A. et al. (7 more authors) (2025) Artificial intelligence-based Raynaud’s quantification index (ARTIX): an objective mobile-based tool for patient-centered assessment of Raynaud’s phenomenon. Arthritis Research & Therapy, 27. 120. ISSN 1478-6354

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Di Battista, M., Redmond, A.C. orcid.org/0000-0002-8709-9992 et al. (4 more authors) (2025) Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis. Rheumatology. keaf047. ISSN 1462-0324

Di Battista, M. orcid.org/0000-0002-4788-5729, Wasson, C.W., Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (1 more author) (2023) Autonomic dysfunction in systemic sclerosis: A scoping review. Seminars in Arthritis and Rheumatism, 63. 152268. ISSN 0049-0172

Di Battista, M., Barsotti, S., Orlandi, M. et al. (5 more authors) (2021) One year in review 2021: systemic sclerosis. Clinical and Experimental Rheumatology, 39 (4). S3-S12. ISSN 0392-856X

Conference or Workshop Item

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain.

Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Di Battista, M., Redmond, A.C. orcid.org/0000-0002-8709-9992 et al. (4 more authors) (2024) Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy. In: ACR Convergence 2024, 14-19 Nov 2024, Washington, D.C..

Proceedings Paper

Kakkar, V., Kim, S., Bi, Y. et al. (7 more authors) (2025) ABS0025 GROWTH DIFFERENTIATION FACTOR 15 IS A SERUM BIOMARKER AND PATHOGENIC FACTOR OF PROGRESSIVE FIBROSIS IN SYSTEMIC SCLEROSIS. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , p. 2264.

Kakkar, V., Kim, S., Bi, Y. et al. (7 more authors) (2025) Growth Differentiation Factor 15 is a Serum Biomarker and Pathogenic Factor of Progressive Fibrosis in Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , p. 2264.

Campochiaro, C., Mongin, D., Courvoisier, D.S. et al. (16 more authors) (2025) OP0082 Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 72-73.